GoldenGolden
Nevro

Nevro

Nevro is a medical device company with the simple goal of helping more patients who are suffering from chronic pain to achieve lasting relief.

Nevro is a medical device company with the simple goal of helping more patients who are suffering from chronic pain to achieve lasting relief. Nevro pursues clinical research to better support healthcare providers in treating chronic pain.

The company creates HFX, a comprehensive solution for individualized relief of chronic pain to help physicians to meet the diverse needs of patients by providing: Innovative Technologies, Advanced Therapies, Services & Support and Meaningful Evidence.

Nevro created a disruption by offering a next-generation approach called 10 kHz Therapy, the most studied therapy in the market, that provides patients with significant pain relief and no paresthesia.

The company's product, Nevro® Senza® SCS System for 10 kHz Therapy, received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.

Timeline

March 7, 2013
Nevro raises a $48,000,000 series C round from Accuitive Medical Ventures, Bay City Capital, Covidien Ventures, Johnson & Johnson Development Corporation, MPM Capital, Mayo Clinic, New Enterprise Associates, Novo Ventures and Three Arch Partners.

Funding rounds

People

Name
Role
LinkedIn

Alireza Modafe

Employee

Alok Subbarao

Employee

Anthony Puglisi

Employee

Anura Patil

Employee

Aryan Samuel

Employee

Brandan Richardson

Employee

Bret Foreman

Employee

Carlo Marcelo

Employee

Christine Fernandez

Employee

Cody Nguyen

Employee

DiAna Talesfore-Ramirez

Employee

Eric Boulogne

Employee

James Kestell

Employee

James Min

Employee

Jay Nguyen

Employee

Jim Borninski

Employee

Jimmy Lin

Employee

Justin Klein

Investor

Kishore Ramachandramurthy

Employee

Lorraine Paranal, MHA

Employee

Madison Butler

Employee

Mark Stultz

Employee

Mary Helen Esposito

Employee

Michael Joo

Employee

Nick Ben

Employee

Page 1 of 2

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Nevro Corp.
April 19, 2021
www.prnewswire.com:443
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...
Nevro Corp.
December 22, 2020
www.prnewswire.com:443
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...
Nevro Corp.
November 24, 2020
www.prnewswire.com:443
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...
Nevro Corp.
November 17, 2020
www.prnewswire.com:443
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.